Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center

Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center

Understanding of immune-related adverse events (irAEs) has evolved rapidly, and management guidelines are continually updated. We explored temporal changes in checkpoint inhibitor-induced irAE management at a tertiary cancer care center to identify areas for improvement. We conducted a single-center...

Full description

Bibliographic Details
Main Authors: Malek Shatila, Farzin Eshaghi, Austin R. Thomas, Andrew G. Kuang, Jay S. Shah, Brandon Zhao, Sidra Naz, Mianen Sun, Sarah Fayle, Jeff Jin, Ala Abudayyeh, Ajay Sheshadri, Nicolas L. Palaskas, Maria C. Franco-Vega, Maria S. Gaeta, Anusha S. Thomas, Hao Chi Zhang, Yinghong Wang
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cancers
Subjects:
immunotherapy
quality improvement
immune-mediated colitis
pneumonitis
carditis
Online Access:https://www.mdpi.com/2072-6694/16/2/369

Internet

https://www.mdpi.com/2072-6694/16/2/369

Similar Items